These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3936410)

  • 1. The interferon system as a basis for antiviral therapy or prophylaxis.
    Billiau A
    Antiviral Res; 1985; Suppl 1():131-40. PubMed ID: 3936410
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
    Schellekens H; van Eerd PM; de Reus A; Weck PK; Stebbing N
    Antiviral Res; 1982 Oct; 2(5):313-8. PubMed ID: 6817709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
    Sáez-Royuela F; Porres JC; Moreno A; Castillo I; Martinez G; Galiana F; Carreño V
    Hepatology; 1991 Feb; 13(2):327-31. PubMed ID: 1899852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferon in the treatment of viral, neoplastic and immunologic diseases].
    Inglot AD
    Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.
    van der Meide PH; Harteveld N; Stebbing N; Schellekens H
    Antiviral Res; 1985; Suppl 1():199-207. PubMed ID: 3936413
    [No Abstract]   [Full Text] [Related]  

  • 8. Interferon-induced reversible acute renal failure with nephrotic syndrome.
    Nair S; Ernstoff MS; Bahnson RR; Arthur S; Johnston J; Downs MA; Neuhart J; Kirkwood JM
    Urology; 1992 Feb; 39(2):169-72. PubMed ID: 1736513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
    Sim IS; Cerruti RL
    Antiviral Res; 1987 Nov; 8(4):209-21. PubMed ID: 3128162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical use of interferon in viral infections.
    Levin S
    Isr J Med Sci; 1983 Nov; 19(11):955-8. PubMed ID: 6198305
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferons in therapeutics.
    Wardle EN
    Br J Hosp Med; 1989 Jan; 41(1):99. PubMed ID: 2493959
    [No Abstract]   [Full Text] [Related]  

  • 12. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.
    Bartsch HH; Pfizenmaier K; Hanusch A; Scheurich P; Ucer U; Nagel GA
    Int J Cancer; 1989 Feb; 43(2):235-40. PubMed ID: 2521842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-species antiviral activity of a recombinant human alpha-interferon hybrid.
    Ghaffar A; Mayer EP; Barnhart DC; Pyo S; Szymaniec S; Hochkeppel HK; Gangemi JD
    Ann N Y Acad Sci; 1992 Jun; 653():314-22. PubMed ID: 1320843
    [No Abstract]   [Full Text] [Related]  

  • 14. A brief history of the use of interferons as treatment of multiple sclerosis.
    Jacobs L; Johnson KP
    Arch Neurol; 1994 Dec; 51(12):1245-52. PubMed ID: 7986181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferon (IFN) therapy (recombinant IFN-alpha-2C or recombinant IFN-gamma) in metastasized hypernephroma].
    Kuzmits R; Scheithauer W; Ludwig H; Flener R
    Acta Med Austriaca; 1985; 12(5):129-34. PubMed ID: 3938590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
    Kloke O; Becher R; Niederle N
    Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia.
    Tamura K; Makino S; Araki Y; Imamura T; Seita M
    Cancer; 1987 Mar; 59(6):1059-62. PubMed ID: 2880655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of primary progressive follicular mucinosis with interferons.
    Meissner K; Weyer U; Kowalzick L; Altenhoff J
    J Am Acad Dermatol; 1991 May; 24(5 Pt 2):848-50. PubMed ID: 1828814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha- and gamma-interferon versus alpha-interferon alone in chronic hepatitis B. A randomized controlled study.
    Carreño V; Moreno A; Galiana F; Bartolomé FJ
    J Hepatol; 1993 Mar; 17(3):321-5. PubMed ID: 8315260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.